| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.005 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |